Argenica Therapeutics Limited

A$0.10As of Sun 8 Nov 2026, 12:00 UTC
ASX:AGNHealthcare
Country Australia
PE (Fwd) •••
TSR 5Y CAGR (12.97%)
Div yield —
ROE (20.78%)
Biotechnology
Beta (5Y) 1.52
PE TTM —
TSR TTM (65.45%)
Mkt cap A$12.20M
ROIC (15.00%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.12
26.19%
120.36%
Hold 5|11|10|11|11
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
1.05%
11.25%
15.14%
13.45%
Revenue$M
1.422
1.445
1.512
1.481
16.63%
19.84%
18.38%
9.53%
Peers (US$8.381M)
Cap (US$)
PE
8.797M
—
8.031M
—
7.761M
—
Capital
TTM
5Y
10Y
Leveragex
0.144
(0.045)
(0.039)
EBIT/Intx
3.762
0.319
0.294
Own earn%
(45.22)
(205.45)
(161.50)
Sh yield%
39.73
15.86
17.32
Owners
Insiders/Inst%
9.58
51.43
Short interest%
0.58
SBC / revenue%
4.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
31–41
$1 testx
—
Incr. ROIC%
15